NCT06151301

Brief Summary

Hydrocarbons are a primary energy source in modern society. They are present in many common household and occupational products, including motor fuels, paint thinners, cleaning agents, lotions, and industrial solvents. Unfortunately, these products are also used as agents of abuse and typically inhaled . They are derived mainly from petroleum (kerosene, gas, naphtha) or wood (turpentine, pine oil). They can be found in liquid, gas, or solid form depending on their properties. All hydrocarbons can be toxic, but aromatic (ring-shaped) and halogenated hydrocarbons typically have more severe toxicity . Toxicity occurs in various ways including through inhalation, ingestion, aspiration, and dermal exposure. Frequently, these exposures occur during attempted recreational use of the substances and sometimes for self-injurious behavior

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 30, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

November 21, 2023

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Serum procalcitonin level

    measuring the level of serum procalcitonin (reference range 0-0.05µg/L)

    1 year

Study Arms (2)

control group

20 subjects of apparently healthy persons for estimating the standard levels of the tested biomarkers.

Diagnostic Test: serum procalcitoninDiagnostic Test: C-reactive protein

case group

60 patients divided into mild, moderate and severe toxicity according to the poisoning severity score.

Diagnostic Test: serum procalcitoninDiagnostic Test: C-reactive protein

Interventions

serum procalcitoninDIAGNOSTIC_TEST

predicting the severity of intoxication

case groupcontrol group
C-reactive proteinDIAGNOSTIC_TEST

predicting the severity of intoxication

case groupcontrol group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients of both sexes admitted to the Poison control center, Ain Shams university hospitals with acute hydrocarbon toxicity during the duration from December 2023 till December 2024 with a maximum number of 60 cases within 24 hours of intoxication

You may qualify if:

  • Patients of both sexes admitted to the Poison control center, Ain Shams university hospitals with acute hydrocarbon toxicity during the duration from December 2023 till December 2024 with a maximum number of 60 cases within 24 hours of intoxication.

You may not qualify if:

  • Patients with these criteria will be excluded:
  • Cases \> 24 hours of intoxication.
  • Cases with occupational exposure to hydrocarbons.
  • Pregnant females.
  • Any cases received any treatment before arrival to the PCC.
  • Cases suffering from cardiac, respiratory, renal, hepatic or haematological disorders.
  • Cases presenting with fever.
  • Cases with other causes that can increase levels of CRP \& pro-calcitonin as bacterial infection, recent major trauma, major burn ,septic shock and medullary thyroid cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams university Hospital

Cairo, Egypt

Location

Central Study Contacts

Mera G Khalil, assistant lecutrer

CONTACT

Maha A Helal, professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecteurer Forensic medicine and Toxicology department sohag univerisity hospital

Study Record Dates

First Submitted

November 21, 2023

First Posted

November 30, 2023

Study Start

December 1, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

November 30, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations